Company: IXHL
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001213900-25-092837
Chunk: 543

Company: Incannex Healthcare Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 2
Chunk 543
---

    Stockholders’ equity: 

    Common stock, $0.0001 par value – 800,000,000 shares authorized; 194,379,996 and 17,642,832 shares issued and outstanding at June 30, 2025 and 2024, respectively 
     20  
     2 
  
    Preferred stock, $0.0001 par value per share, 10,000,000 shares authorized; no shares issued or outstanding at June 30, 2025 and 2024, respectively 
     -  
     - 
  
    Additional paid-in capital 
     174,049  
     125,218 
  
    Accumulated deficit 
     (157,556) 
     (110,671)
  
    Foreign currency translation reserve 
     (3,124) 
     (3,332)
  
    Total stockholders’ equity 
     13,389  
     11,217 
  
    Total liabilities and stockholders’ equity 
    $20,447  
    $17,047 

The accompanying notes are an integral part of
these consolidated financial statements.

F-3

INCANNEX HEALTHCARE INC.

Consolidated Statements of Operations and Comprehensive
Loss

(in thousands, except share and per share amounts)

(expressed
in U.S. Dollars, unless otherwise stated)

    For the fiscal year ended June 30, 

    2025  
    2024 
  
    Revenue from customers 
     86  
     12 
  
    Operating expenses: 

    Research and development 
     (10,747) 
     (12,879)
  
    General and administrative 
     (13,128) 
     (17,174)
  
    Total operating expenses 
     (23,875) 
     (30,053)
  
    Loss from operations 
     (23,789) 
     (30,041)
  
    Other income, net: 

    R&D tax incentive 
     1,756  
     11,434 
  
    Foreign exchange expense 
     (289) 
     (28)
  
    Interest expense 
     (303) 
     - 
  
    Interest income 
     62  
     206 
  
    Change in fair value of convertible rights 
     299  
     -